Clover Health Investments, Corp vs Johnson & Johnson — Stock Comparison
Q·Score Breakdown
5.3
Bearish
Overall
7.1
Bullish
Quality
Health
Growth
Valuation
Sentiment
CLOV
Clean balance sheet with low leverage (0.0× debt-to-equity).
⚠ currently unprofitable (-4% margin).
JNJ
High-quality business with 26% return on equity and 22% profit margins.
⚠ earnings contracting 53% year-over-year.
Analyst Consensus
HOLD
Target $2.82 (+3.9%)
3 analysts
BUY
Target $252.42 (+11.1%)
24 analysts
Fundamentals
CLOV
JNJ
—
Trailing P/E
26.3×
30.1×
Forward P/E
17.9×
-4.4%
Profit Margin
21.8%
18.5%
Gross Margin
68.0%
-26.3%
ROE
26.4%
44.7%
Revenue Growth
9.9%
—
Earnings Growth
-52.9%
2.25
Beta
0.33
—
Price / Book
—
$1.4B
Market Cap
$546.9B
$2 – $4
52-Week Range
$146 – $252
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →